News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Integra Therapeutics
Integra Therapeutics closes a new investment of €1.5-million with the addition of Columbus Venture Partners to seed round
The biotechnology firm completes the seed round funding with a total of €6 million led last…
adverse event
Safety reporting for clinical investigations under the EU Medical Device Regulation
Safety reporting is a crucial aspect of a successful clinical investigation for medical devices.…
oryzon
ORYZON announces appointment of Douglas V. Faller, MD, PhD as Global Chief Medical Officer and continues its expansion of US corporate activities
Healthcare
Extensive academic and industry experience in hematology/oncology Will coordinate Oryzon’s global…
oryzon
ORYZON to give updates on corporate progress in March and April
Healthcare
Virtual Bio-Europe Spring 2022 Kempen Life Sciences Conference Asebio Investor Day
sermes cro
Spanish clinical research entities start submitting the first clinical trials through CTIS, the new European clinical trials portal
Healthcare
Sermes CRO, together with Mikrobiomik, manages the first submission of a clinical trial in Spain…
asphalion objetivos
Asphalion releases its 2022 CSR plan demonstrating commitment towards UN 2030 sustainable development goals
Asphalion is enhancing its Corporate Social Responsibility programme with significant …
Algenex Food Technology Market
Algenex Announces Entry into the Food Technology Market
Food & feed · Industrial biotechnology
Spanish biotech Algenex announces its expansion into the food tech market. The Company’s patented…
carlos sebastian
Connection shown between glucose metabolism and colorectal tumorigenesis
Healthcare
The results of the study, published in Nature Communications, open up a new path for research to…
oryzon pic
ORYZON announces FDA approval of IND for FRIDA, a Phase Ib trial with iadademstat in R/R AML FLT3mut+ patients
Healthcare
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D…